SANGUINE BIOSCIENCES, INC
- WOBURN, MA 01801-6571
- sanguinebio.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $177.7K
- Awards on record
- 2
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
SANGUINE BIOSCIENCES, INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About SANGUINE BIOSCIENCES, INC
- Headquarters
- WOBURN, MA 01801-6571
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIK2BANCKDAJJ9
- CAGE7EQX5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $177.7K
- Awards on record
- 2
- Top funding agencies
- National Institute of Standards and Technology · Centers for Disease Control and Prevention
Awards
1333ND26PNB640598
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)OU63-FY26-278-NEW BLOOD COLLECTION SAMPLE SERVICES.
Department of Commerce · National Institute of Standards and Technology
- Obligated
- $100K
- Period of performance
- Oct 1, 2026 – Sep 30, 2027
75D30124P19767
Completed: Period of performance ended Dec 20, 2024SANGUINE BIO CONJUNCTIVAL SWAB MATRIX PROSPECTIVE COLLECTION
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $77.7K
- Period of performance
- Aug 20, 2024 – Dec 20, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
1333ND26PNB640598 OU63-FY26-278-NEW BLOOD COLLECTION SAMPLE SERVICES. | Department of Commerce · National Institute of Standards and Technology | 621511 · AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $100K | Oct 1, 2026 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award 1333ND26PNB640598Bid team for the recompete of award 1333ND26PNB640598 |
75D30124P19767 SANGUINE BIO CONJUNCTIVAL SWAB MATRIX PROSPECTIVE COLLECTION | Department of Health and Human Services · Centers for Disease Control and Prevention | 621511 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $77.7K | Aug 20, 2024 – Dec 20, 2024 | Completed: Period of performance ended Dec 20, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 1 award
- Total awarded
- $224,981
- By phase
- SBIR Phase I: 1
- By agency
- National Science Foundation: 1
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2019: 1
Awards (most recent first)
SBIR Phase I: Advanced Direct-To-Patient Data Aggregation Platform For Clinical Trial Recruitment.
SBIR Phase I · National Science Foundation · 2019 · $224,981
Feb 1, 2019 – Jul 31, 2019
Solicitation year 2018 · Topic DH
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325414Biological Product (except Diagnostic) ManufacturingPrimarySmall business under this code’s size standard
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Small business under this code’s size standard
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov reports this entity as small under 2 of 3 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- 6505DRUGS AND BIOLOGICALS
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with SANGUINE BIOSCIENCES, INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
